131 related articles for article (PubMed ID: 23479071)
1. Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension.
Tousoulis D; Androulakis E; Papageorgiou N; Miliou A; Chatzistamatiou E; Oikonomou E; Moustakas G; Kallikazaros I; Stefanadis C
Am J Hypertens; 2013 May; 26(5):683-90. PubMed ID: 23479071
[TBL] [Abstract][Full Text] [Related]
2. Genetic background of left ventricular hypertrophy in Uzbek hypertensive men.
Kurbanova D; Eliseyeva M
Turk Kardiyol Dern Ars; 2010 Oct; 38(7):466-72. PubMed ID: 21206199
[TBL] [Abstract][Full Text] [Related]
3. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
[TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.
Alves GB; Oliveira EM; Alves CR; Rached HR; Mota GF; Pereira AC; Rondon MU; Hashimoto NY; Azevedo LF; Krieger JE; Negrão CE
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):487-92. PubMed ID: 19404196
[TBL] [Abstract][Full Text] [Related]
5. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population.
Abdel Ghafar MT
Clin Exp Hypertens; 2019; 41(8):779-786. PubMed ID: 30561227
[No Abstract] [Full Text] [Related]
6. Cystatin C and cardiac hypertrophy in primary hypertension.
Prats M; Font R; Bardají A; Gutierrez C; Lalana M; Vilanova A; Martinez-Vea A
Blood Press; 2010 Feb; 19(1):20-5. PubMed ID: 20113216
[TBL] [Abstract][Full Text] [Related]
7. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
9. Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2.
Isaji M; Mune T; Takada N; Yamamoto Y; Suwa T; Morita H; Takeda J; White PC
J Hypertens; 2005 Jun; 23(6):1149-57. PubMed ID: 15894890
[TBL] [Abstract][Full Text] [Related]
10. Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study.
Tang W; Devereux RB; Rao DC; Oberman A; Hopkins PN; Kitzman DW; Arnett DK
Am Heart J; 2002 May; 143(5):854-60. PubMed ID: 12040348
[TBL] [Abstract][Full Text] [Related]
11. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
Ito O; Okamoto M; Murakami Y; Nakayama R
J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
[TBL] [Abstract][Full Text] [Related]
12. Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients.
Lacchini R; Jacob-Ferreira AL; Luizon MR; Gasparini S; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
J Hum Hypertens; 2012 Mar; 26(3):171-7. PubMed ID: 21307882
[TBL] [Abstract][Full Text] [Related]
13. Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy.
Malmqvist K; Wallén HN; Held C; Kahan T
J Hypertens; 2002 Aug; 20(8):1563-9. PubMed ID: 12172318
[TBL] [Abstract][Full Text] [Related]
14. Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes.
Sookoian S; Gianotti TF; Pirola CJ
Heart; 2008 Jul; 94(7):903-10. PubMed ID: 17698557
[TBL] [Abstract][Full Text] [Related]
15. Angiotensinogen M235T polymorphism and left ventricular indices in treated hypertensive patients with normal coronary arteries.
Olcay A; Nişanci Y; Ekmekçi CG; Ozbek U; Sezer M; Umman B; Buğra Z
Anadolu Kardiyol Derg; 2007 Sep; 7(3):257-61. PubMed ID: 17785212
[TBL] [Abstract][Full Text] [Related]
16. Context-dependency of the relation between left ventricular mass and AGT gene variants.
Kuznetsova T; Staessen JA; Reineke T; Olszanecka A; Ryabikov A; Tikhonoff V; Stolarz K; Bianchi G; Casiglia E; Fagard R; Brand-Herrmann SM; Kawecka-Jaszcz K; Nikitin Y; Brand E;
J Hum Hypertens; 2005 Feb; 19(2):155-63. PubMed ID: 15483663
[TBL] [Abstract][Full Text] [Related]
17. [Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].
Vasilyeva MP; Rudenko TE; Kutyrina IM; Solomakhina NI
Ter Arkh; 2015; 87(6):17-22. PubMed ID: 26281190
[TBL] [Abstract][Full Text] [Related]
18. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function.
Albayrak S; Ordu S; Ozhan H; Yazici M; Aydin M; Alemdar R; Kaya A
Blood Press; 2009; 18(4):187-91. PubMed ID: 19521888
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women.
Masiha S; Sundström J; Lind L
J Hum Hypertens; 2013 Jan; 27(1):13-7. PubMed ID: 22237633
[TBL] [Abstract][Full Text] [Related]
20. [Role of the M235T (c.704c>T) polymorphism of angiotensynogen gene as well as A724A (c.2171G>A) polymorphism of SERCA2a gene in ethiopathogenesis of left ventricular hypertrophy in essential hypertension].
Kieć-Wilk B; Olszanecka A; Mikołajczyk M; Kawecka-Jaszcz K
Przegl Lek; 2010; 67(3):151-6. PubMed ID: 20687374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
